0 Комментарии
0 Поделились
124 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Carcinoembryonic Antigen (CEA) Market Regional Analysis, Demand Analysis and Competitive Outlook 2026-2033According to a newly published market research report by 24LifeSciences, global Carcinoembryonic Antigen (CEA) market was valued at USD 1.73 billion in 2024 and is projected to reach USD 2.33 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.4% during the forecast period 20252031. Carcinoembryonic antigen (CEA), a critical glycoprotein biomarker, plays an essential role in...0 Комментарии 0 Поделились 226 Просмотры 0 предпросмотр
-
Carcinoembryonic Antigen (CEA) Market: Cancer Biomarker Testing, Diagnostic Kits, and Monitoring Applications in OncologyExecutive Summary: The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC). The market is...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Carcinoembryonic Antigen (CEA) Market: Colorectal Cancer Screening, High-Sensitivity Multiplex Immunoassays, and Companion Diagnostic Trends"Executive Summary Carcinoembryonic Antigen (CEA) Market Size and Share Across Top Segments Data Bridge Market Research analyses that the carcinoembryonic antigen (CEA) market which was USD 1,855.41 million in 2021, is expected to reach USD 2,912.90 million by 2029, at a CAGR of 5.80% during the forecast period 2022 to 2029. By utilizing few steps or a number of steps, the process of...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Carcinoembryonic Antigen Market Analysis: Emerging Applications and ForecastThe Carcinoembryonic Antigen Market is moving toward more integrated approaches to cancer diagnostics as healthcare providers seek better ways to combine biomarkers, laboratory testing, and personalized treatment strategies. The market's projected growth to nearly USD 6.90 billion by 2035 highlights the expanding commercial opportunity surrounding CEA testing technologies. One important...0 Комментарии 0 Поделились 129 Просмотры 0 предпросмотр
-
Future Growth Prospects of the Global Carcinoembryonic Antigen Market 2035The Carcinoembryonic Antigen Market is expected to maintain steady growth through 2035 as cancer surveillance, laboratory automation, and diagnostic infrastructure continue to develop. CEA remains an important tumor marker, particularly for colorectal cancer monitoring, while emerging applications across liver, lung, pancreatic, and breast cancers are supporting broader demand. Market Research...0 Комментарии 0 Поделились 181 Просмотры 0 предпросмотр